CompletedNot Applicable

Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block

China140 participantsStarted 2022-04-15

Plain-language summary

Paravertebral block (PVB) has been regarded as effective regimen for pain control after cardiac surgery. As a novel analgesia technique, erector spinae plane block (ESPB) has been reported to provide effective analgesia after thoracic and cardiac surgery. We hypothesized that the ESPB is non-inferior to PVB in treating pain in minimally invasive direct coronary artery bypass surgery.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Contraindications to regional anesthesia (coagulopathy, infection of the skin at the site of needle puncture area, et al)
✕. Morbid obesity (body mass index \> 35 kg/m2)
✕. Allergy to any of the study drugs
✕. Chronic opioid use or history of opioid abuse.
✕. Inability to understand pain score

What they're measuring

pain at cough after surgery

Timeframe: postoperatively 0-3 day

postoperative rescue analgesic consumption

Timeframe: postoperatively 0-3 day

Trial details

NCT IDNCT05320718

SponsorPeking University Third Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-30

View on ClinicalTrials.gov More Regional Anesthesia trials